REG - Cambridge Cognition - Directorate Change
RNS Number : 9931QCambridge Cognition Holdings PLC02 November 2021Cambridge Cognition Holdings Plc (AIM: COG)
('Cambridge Cognition' or the 'Company')
Directorate Change
Cambridge Cognition Holdings Plc, which develops and markets digital solutions to assess brain health, announces that Michael Holton, Chief Financial Officer, will stand down from the Company's Board with immediate effect to focus on other opportunities.
The Board is looking to appoint a replacement Chief Financial Officer, further details of which will be announced in due course. In the intervening period, Nick Walters, Cambridge Cognition's former CFO who stood down earlier this year, will support the Company during the transition.
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.
Enquiries
Cambridge Cognition Holdings Plc
Matthew Stork, Chief Executive Officer
Tel: 01223 810 700
finnCap Ltd (NOMAD and Joint Broker)
Geoff Nash / Simon Hicks
Alice Lane / Charlotte Sutcliffe
Tel: 020 7220 0500
(Corporate Finance)
(Corporate Broking)
Dowgate Capital Limited (Joint Broker)
David Poutney / James Serjeant
Tel: 020 3903 7715
IFC Advisory Ltd (Financial PR and IR)
Tim Metcalfe / Graham Herring / Zach Cohen
Tel: 020 3934 6630
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDBOAMZMGMMMNGMZZ
Recent news on Cambridge Cognition Holdings
See all newsREG - Cambridge Cognition - Preliminary Results, Trading Update & Board Change
AnnouncementREG - Cambridge Cognition - Notice of Results
AnnouncementREG - Cambridge Cognition - COG spin-out Monument Therapeutics accesses £1.5m
AnnouncementREG - Cambridge Cognition - Total Voting Rights and Block Listing Return
AnnouncementREG - Cambridge Cognition - Formation of new Scientific Advisory Board
Announcement